Fumonisin B1 modulates expression of human cytochrome P450 1b1 in human hepatoma (Hepg2) cells by repressing Mir-27b

Toxicology Letters

Volumn 227, Issue 1, 2014, Pages 50-55

  Chuturgoon, Anil A ^a   Phulukdaree, Alisa ^a   Moodley, Devapregasan ^a,b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cytochrome P 450 (CYP1B1); HepG2 cells; Liver cancer; MicroRNA (miR) 27b

Indexed keywords

CYTOCHROME P450 1B1; FUMONISIN B1; MICRORNA; MICRORNA 27B; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

CYTOCHROME P 450 (CYP1B1); FUMONISIN B(1); HEPG2 CELLS; LIVER CANCER; MICRORNA (MIR)-27B;

ARYL HYDROCARBON HYDROXYLASES; CARCINOGENS, ENVIRONMENTAL; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; CLUSTER ANALYSIS; DOWN-REGULATION; ENZYME INDUCTION; FUMONISINS; HEP G2 CELLS; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MICRORNAS; MOLECULAR MIMICRY; NEOPLASM PROTEINS; RNA, MESSENGER; TRANSFECTION;

EID: 84897952202     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.02.026     Document Type: Article

References (22)

1. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
2. Bandiera S., Weidlich S., Harth V., Broede P., Ko Y., Friedberg T. Proteasomal degradation of human CYP1B1: effect of the Asn453Ser polymorphism on the post-translational regulation of CYP1B1 expression. Molecular Pharmacology 2005, 67:435-443.
3. Biyashev D., Veliceasa D., Topczewski J., Topczewska J.M., Mizgirev I., Vinokour E., Reddi A.L., Licht J.D., Revskoy S.Y., Volpert O.V. miR-27b controls venous specification and tip cell fate. Blood 2012, 119:2679-2687.
4. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nature Reviews. Cancer 2006, 6:857-866.
5. Chen C.Z. MicroRNAs as oncogenes and tumor suppressors. New England Journal of Medicine 2005, 353:1768-1771.
6. Cheung Y.L., Kerr A.C., McFadyen M.C., Melvin W.T., Murray G.I. Differential expression of CYP1A1, CYP1A2, CYP1B1 in human kidney tumours. Cancer Letters 1999, 139:199-205.
7. 1 induces global DNA hypomethylation in HepG2 cells - an alternative mechanism of action. Toxicology 2014, 315:65-69.
8. Gelderblom W.C., Marasas W.F. Controversies in fumonisin mycotoxicology and risk assessment. Human & Experimental Toxicology 2012, 31:215-235.
9. Gusev Y. Computational methods for analysis of cellular functions and pathways collectively targeted by differentially expressed microRNA. Methods 2008, 44:61-72.
10. Han X., Liehr J.G. 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: role of free radicals in estrogen-induced carcinogenesis. Cancer Research 1994, 54:5515-5517.
11. 1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice. Environmental Health Perspectives 2001, 109(Suppl. 2):277-282.
12. Lee A.J., Cai M.X., Thomas P.E., Conney A.H., Zhu B.T. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology 2003, 144:3382-3398.
13. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
14. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
15. Maziere P., Enright A.J. Prediction of microRNA targets. Drug Discovery Today 2007, 12:452-458.
16. McFadyen M.C., Murray G.I. Cytochrome P450 1B1: a novel anticancer therapeutic target. Future Oncology 2005, 1:259-263.
17. Newbold R.R., Liehr J.G. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Research 2000, 60:235-237.
18. Norred W.P., Voss K.A., Riley R.T., Meredith F.I., Bacon C.W., Merrill A.H. Mycotoxins and health hazards: toxicological aspects and mechanism of action of fumonisins. Journal of Toxicological Sciences 1998, 23(Suppl. 2):160-164.
19. Ragavan N., Hewitt R., Cooper L.J., Ashton K.M., Hindley A.C., Nicholson C.M., Fullwood N.J., Matanhelia S.S., Martin F.L. CYP1B1 expression in prostate is higher in the peripheral than in the transition zone. Cancer Letters 2004, 215:69-78.
20. Shimada T., Hayes C.L., Yamazaki H., Amin S., Hecht S.S., Guengerich F.P., Sutter T.R. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Research 1996, 56:2979-2984.
21. Tokizane T., Shiina H., Igawa M., Enokida H., Urakami S., Kawakami T., Ogishima T., Okino S.T., Li L.C., Tanaka Y., Nonomura N., Okuyama A., Dahiya R. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clinical Cancer Research 2005, 11:5793-5801.
22. Tsuchiya Y., Nakajima M., Takagi S., Taniya T., Yokoi T. MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Research 2006, 66:9090-9098.